These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26049281)

  • 1. Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis.
    Zwerling AA; Sahu M; Ngwira LG; Khundi M; Harawa T; Corbett EL; Chaisson RE; Dowdy DW
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):83-90. PubMed ID: 26049281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Tuberculosis With Xpert MTB/RIF Assay Versus Fluorescent Microscopy Among Adults Newly Diagnosed With Human Immunodeficiency Virus in Rural Malawi: A Cluster Randomized Trial (Chepetsa).
    Ngwira LG; Corbett EL; Khundi M; Barnes GL; Nkhoma A; Murowa M; Cohn S; Moulton LH; Chaisson RE; Dowdy DW
    Clin Infect Dis; 2019 Mar; 68(7):1176-1183. PubMed ID: 30059995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB).
    Hanrahan CF; Nonyane BAS; Mmolawa L; West NS; Siwelana T; Lebina L; Martinson N; Dowdy DW
    PLoS Med; 2019 Apr; 16(4):e1002796. PubMed ID: 31039165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.
    Abimbola TO; Marston BJ; Date AA; Blandford JM; Sangrujee N; Wiktor SZ
    J Acquir Immune Defic Syndr; 2012 May; 60(1):e1-7. PubMed ID: 22240465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis.
    Jha S; Ismail N; Clark D; Lewis JJ; Omar S; Dreyer A; Chihota V; Churchyard G; Dowdy DW
    PLoS One; 2016; 11(6):e0157554. PubMed ID: 27322162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.
    Fenner L; Ballif M; Graber C; Nhandu V; Dusingize JC; Cortes CP; Carriquiry G; Anastos K; Garone D; Jong E; Gnokoro JC; Sued O; Ajayi S; Diero L; Wools-Kaloustian K; Kiertiburanakul S; Castelnuovo B; Lewden C; Durier N; Sterling TR; Egger M;
    PLoS One; 2013; 8(10):e77697. PubMed ID: 24147059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    Mbu ET; Sauter F; Zoufaly A; Bronsvoort BMC; Morgan KL; Noeske J; Abena JF; Sander MS
    PLoS One; 2018; 13(6):e0199634. PubMed ID: 29944701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.
    Ballif M; Renner L; Claude Dusingize J; Leroy V; Ayaya S; Wools-Kaloustian K; Cortes CP; McGowan CC; Graber C; Mandalakas AM; Mofenson LM; Egger M; Kumara Wati KD; Nallusamy R; Reubenson G; Davies MA; Fenner L; ;
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):30-8. PubMed ID: 26407355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the benefit of different complementary exams in the search for a TB diagnosis algorithm for HIV patients put on ART in Niamey, Niger].
    Ouedraogo E; Lurton G; Mohamadou S; Dillé I; Diallo I; Mamadou S; Adehossi E; Hanki Y; Tchousso O; Arzika M; Gazeré O; Amadou F; Illo N; Abdourahmane Y; Idé M; Alhousseini Z; Lamontagne F; Deze C; D'Ortenzio E; Diallo S
    Bull Soc Pathol Exot; 2016 Dec; 109(5):368-375. PubMed ID: 27848101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus.
    Reddy KP; Denkinger CM; Broger T; McCann NC; Gupta-Wright A; Kerkhoff AD; Pei PP; Shebl FM; Fielding KL; Nicol MP; Horsburgh CR; Meintjes G; Freedberg KA; Wood R; Walensky RP
    Clin Infect Dis; 2021 Oct; 73(7):e2077-e2085. PubMed ID: 33200169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality.
    Cantwell MF; Binkin NJ
    Tuber Lung Dis; 1996 Jun; 77(3):220-5. PubMed ID: 8758104
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.